Christopher Paul Fox

27PUBLICATIONS

148CO-AUTHORS

Haematological tumoursPredictive and prognostic markersMetabolic medicineEpidemiological methodsTumour immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (27)

Sort by Publication Date:

|Jun 11, 2026

High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

|Apr 22, 2026

Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma.

|Dec 22, 2025

Phased Variant-Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study.

Joanna A Krupka, Ilias Moutsopoulos, Natasha H Cutmore

|Nov 21, 2025

Cost-effectiveness of risk-stratified blood test monitoring strategies for adults with inflammatory conditions.

Matt Stevenson, Georgina Nakafero, Hywel C Williams

|Oct 17, 2024

Real-world outcomes of patients with relapsed/refractory large B-cell lymphoma receiving second-line therapy in England.

Christopher P Fox, William Townsend, John G Gribben

|Oct 02, 2024

A European consensus recommendation on the management of delayed methotrexate elimination: supportive measures, leucovorin rescue and glucarpidase treatment.

Stefan S Bielack, Carole Soussain, Christopher P Fox

Pageof 5

Frequent Collaborators

9 joint publications

Toby A Eyre

8 joint publications

Pamela McKay

6 joint publications

Nicolás Martínez-Calle

Matthew J Ahearne

John N Allan

Kate Cwynarski

Maryam Yazdy

Matthew R Wilson

Kim M Linton

Andrea Sitlinger

Frequent Collaborators

9 joint publications

Toby A Eyre

8 joint publications

Pamela McKay

6 joint publications

Nicolás Martínez-Calle

5 joint publications

Matthew J Ahearne